# Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain

> **NCT01035281** · PHASE3 · UNKNOWN · sponsor: **University of Calgary** · enrollment: 60 (estimated)

## Conditions studied

- Diabetic Neuropathies

## Interventions

- **DRUG:** Nabilone, flexible dosing

## Key facts

- **NCT ID:** NCT01035281
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01035281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01035281, "Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01035281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*